Salubris
00229429.650.44% ( -0.13 )
Overview
Salubris (002294)
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China. The comp...
- Open
- 29.80
- High
- 29.89
- Low
- 29.61
- Prev. Close
- 29.78
- Volume
- 74.28K
- Turnover
- 220.92M
- Avg Price
- 29.74
- Bid/Ask Ratio
- --
- Amplitude
- 0.94%
- 52wk High
- 70.44
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.67%
- 52wk Low
- 29.25
- Float Mkt Cap
- 33.05B
- Market CapCNY
- 33.05B
- P/ETTM
- 46.23
- P/EDynamic
- 38.48
- P/EStatic
- --
- EPSTTM
- 0.641
- EPSDynamic
- 0.770
- EPSStatic
- --
- BVPS
- 7.77
- P/B
- 3.81
- Circulating Supply
- 1.11B
- Dividend YieldTTM
- 1.85%
- DividendTTM
- 0.55
- Shares
- 1.11B
- Min lot size
- 100
- Currency
- CNY
Salubris Analyst Rating
View moreForecast & Rating
Jun 10, 2026Price forecast
¥60.00102.36%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr ·
Shenzhen Salubris Pharmaceuticals : Innovative-product growth lifted 9M revenue 15.47% as net income rose 10.93%
- benzinga_article ·
Salubris Refiles For Hong Kong IPO As Generics Lose Steam
- MorningStar ·
Chinese Pharma Companies Plan Hong Kong Listings
- Zhitong ·
Salubris: Net profit of RMB 215.6 million in the third quarter
- Zhitong ·
Salubris SAL0137 drug clinical trial application accepted
- Zhitong ·
Innovative drug concept experiences a surge, CCHT rises over 8%
